Frederick M. Hudson - 10 Jan 2023 Form 4 Insider Report for SUPERNUS PHARMACEUTICALS, INC. (SUPN)

Role
Director
Signature
/s/ Timothy C. Dec, as attorney-in-fact
Issuer symbol
SUPN
Transactions as of
10 Jan 2023
Net transactions value
+$68,904
Form type
4
Filing time
12 Jan 2023, 16:00:38 UTC
Previous filing
15 Jun 2022
Next filing
24 Feb 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SUPN Common Stock Options Exercise $68,904 +8,722 +39% $7.90 30,985 10 Jan 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SUPN Director Stock Option (Right to Buy) Options Exercise $0 -8,722 -100% $0.000000* 0 10 Jan 2023 Common Stock 8,722 $7.90 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.